[1]
A. Zhanymbetova, D. Begimbetova, A. Kukanova, U. Kairov, A. Bakisheva, and A. Makishev, “CLINICAL EFFICACY AND SAFETY OF VANDETANIB IN METASTATIC MEDULLARY THYROID CARCINOMA: A CASE REPORT”, Eurasian Journal of Applied Biotechnology, no. 3, pp. 381–389, Sep. 2026.